Healthtech funding in Q4 2018
European Healthtech startup funding raised during Q4 2018.
In Q4 2018, 78 European Healthtech companies closed 79 funding rounds and raised €1.0B in equity funding (excluding debt and grants), up 312.2% versus Q4 2017. France led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.0B
+312.2% vs Q4 2017 · excl. debt & grants
Funding rounds
79
+83.7% vs Q4 2017
Companies
78
Top country
France
Rank among sectors
#3
12.0% of sector funding
Top-10 round share
62.4%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q4 2018 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Oct | €205M | 29 |
| Nov | €559M | 23 |
| Dec | €250M | 27 |
Top countries
by € raisedHealthtech — top countries by capital, Q4 2018 — interactive chart.
Data table
| Healthtech — top countries by capital, Q4 2018 | |
|---|---|
| France | €266M |
| Switzerland | €216M |
| UK | €162M |
| Ireland | €99M |
| Denmark | €79M |
| Israel | €65M |
| Belgium | €54M |
| Germany | €46M |
Stage mix
by € raisedHealthtech — stage mix, Q4 2018 — interactive chart.
Data table
| Healthtech — stage mix, Q4 2018 | |
|---|---|
| Other | €396M |
| Series B | €321M |
| Series C | €145M |
| Series A | €126M |
| Seed | €21M |
| Grant | €1.9M |
| Early VC | €1.2M |
| Pre-Seed | €679k |
Exits & M&A
2 Acquisition2 exits.
Top deals
largest disclosed rounds in Q4 2018| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Other | Nov 2018 | €178M |
| Acticor biotech | Series B | Nov 2018 | €153M |
| Galecto Biotech | Series C | Oct 2018 | €79M |
| Inflazome | Series B | Nov 2018 | €40M |
| Camel-IDS | Series A | Nov 2018 | €37M |
| Owlstone Medical | Other | Oct 2018 | €30M |
| Nuritas | Series B | Dec 2018 | €30M |
| CARMAT | Other | Dec 2018 | €30M |
| AMAL | Series B | Nov 2018 | €29M |
| Fluidic Analytics | Other | Nov 2018 | €27M |
| Whiteswell | Series B | Dec 2018 | €26M |
| Renalytix AI | Series A | Nov 2018 | €26M |
| Lumeon | Series C | Dec 2018 | €25M |
| Sight Diagnostics | Series C | Dec 2018 | €25M |
| K Health | Series B | Dec 2018 | €22M |
Top investors
most active in Q4 2018, by deal count- Bpifrance4 deals
- European Investment Bank (EIB)2 deals
- Forbion2 deals
- Kima Ventures2 deals
- Panakès Partners2 deals
- Romulus Capital2 deals
- 14W1 deals
- Abiomed1 deals
- Acg Management - Viveris Management1 deals
- Adrian Lloyd1 deals